PacBio to Participate in the Jefferies Global Healthcare Conference
PacBio (NASDAQ:PACB) announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, at 2:00 PM ET in New York.
Rhea-AI Summary
PacBio (NASDAQ:PACB) announced that management will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 4, 2026, at 2:00 PM ET in New York. A live webcast and 30-day replay will be available on the investor website.
Positive
- None.
Negative
- None.
Details
News Market Reaction – PACB
In the May 22 session, PACB declined 2.40%, reflecting a moderate negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
- Conference date
- June 4, 2026
- Jefferies Global Healthcare Conference fireside chat
- Event time
- 2:00 PM ET
- Scheduled start time for fireside chat
- Webcast replay period
- 30 days
- Replay available for at least 30 days after event
Historical Context
-
Seed financing and collaboration with Blank Bio for RNA foundation models.
-
First major HiFi study on subfertility and pregnancy loss using long-read WGS.
-
Q1 2026 results with flat revenue, improved margins, and 2026 guidance.
-
Compatibility collaboration with Lucid Genomics for tertiary analysis workflows.
-
Announcement of Q1 2026 earnings call timing and access details.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MENLO PARK, Calif., May 21, 2026 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will participate in a fireside chat at the Jefferies’ Global Healthcare Conference on Thursday, June 4, 2026, at 2:00 PM ET in New York, New York.
A live webcast of the event can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcast will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
ir@pacb.com
Media:
pr@pacb.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.